What is vitamin K's role in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vitamin K's Role in Pregnancy

Vitamin K plays a critical role in pregnancy by supporting fetal coagulation factor development and preventing potentially fatal hemorrhagic complications in newborns. 1, 2

Importance of Vitamin K During Pregnancy

Vitamin K is essential during pregnancy for several key reasons:

  • Fetal coagulation development: The fetal liver requires vitamin K to produce functional coagulation factors (II, VII, IX, X)
  • Prevention of hemorrhagic disease: Without adequate vitamin K, newborns face significantly elevated bleeding risks
  • Risk management: The risk of vitamin K deficiency bleeding (VKDB) in newborns is approximately 1/59 (1700/100,000) without prophylaxis 3

Maternal Vitamin K Status and Fetal Impact

Maternal vitamin K status directly impacts the fetus because:

  • Vitamin K antagonists (like warfarin) cross the placenta and can cause:

    • Fetal hemorrhagic complications
    • Increased risk of pregnancy loss 1
    • Potential embryopathy when used in early pregnancy
    • CNS abnormalities with exposure during any trimester 1
  • The fetal liver is immature with naturally low levels of vitamin K-dependent coagulation factors, making vitamin K status particularly important 1

Management Considerations for Pregnant Women on Vitamin K Antagonists

For women on vitamin K antagonist therapy who are planning pregnancy:

  1. Pre-conception counseling is essential regarding risks 1

  2. Medication substitution options:

    • Replace vitamin K antagonists with LMWH or UFH before conception
    • Perform frequent pregnancy tests and substitute LMWH/UFH when pregnancy is achieved 1
  3. Delivery planning:

    • Substitute UFH or LMWH for vitamin K antagonists approximately 3 weeks prior to delivery
    • Discontinue these medications shortly before delivery 1

Newborn Vitamin K Prophylaxis

Vitamin K prophylaxis is critical for all newborns, especially those born to mothers on vitamin K antagonists:

  • Standard recommendation: The American Academy of Pediatrics recommends a single intramuscular dose of phytonadione 0.5 to 1 mg within one hour of birth 4
  • Efficacy: This reduces VKDB risk from 1/59 to 1/100,000 3
  • Special cases: For infants born to mothers on warfarin, immediate vitamin K administration at birth is required with close monitoring for delayed bleeding complications 2

Alternative Anticoagulants During Pregnancy

When anticoagulation is needed during pregnancy:

  • UFH and LMWH are preferred as they do not cross the placenta and are safe for the fetus 1
  • Fondaparinux has limited data in pregnancy and should be used with caution 1
  • Direct thrombin inhibitors have insufficient safety data for pregnancy use 1

Monitoring and Follow-up

For pregnant women on anticoagulants and their newborns:

  • Monitor INR within 24-48 hours after initiating treatment 2
  • For significant elevations, consider vitamin K administration 2
  • For newborns, check for signs of vitamin K deficiency including:
    • Prolonged prothrombin time
    • Normal fibrinogen level and platelet count 5

Common Pitfalls and Caveats

  • Terminology: The historical term "hemorrhagic disease of the newborn" is outdated; "vitamin K deficiency bleeding" (VKDB) is preferred 5
  • Oral vs. intramuscular prophylaxis: While oral vitamin K can prevent classic VKDB, parenteral administration appears more effective for preventing late VKDB, especially in infants with hepatobiliary disease 5
  • Maternal supplementation: Vitamin K supplementation during pregnancy has not been conclusively shown to prevent VKDB in newborns 6
  • Breastfeeding: Breast milk contains very low levels of vitamin K compared to formula, making breastfed infants at higher risk for VKDB without prophylaxis 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Congenital Vitamin K Deficiency Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prevention of Vitamin K Deficiency Bleeding.

Journal of midwifery & women's health, 2016

Research

Vitamin K deficiency bleeding in infants and children.

Seminars in thrombosis and hemostasis, 1995

Research

Vitamin K deficiency and hemorrhage in infancy.

Clinics in perinatology, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.